{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:48:25Z","timestamp":1790516905665,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijantimicag.2011.04.018","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T06:03:28Z","timestamp":1313388208000},"page":"336-340","source":"Crossref","is-referenced-by-count":16,"title":["Activity of an Intralipid formulation of nystatin in murine systemic candidiasis"],"prefix":"10.1016","volume":"38","author":[{"given":"R.","family":"Semis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mendlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Polacheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2011.04.018_bib0005","doi-asserted-by":"crossref","first-page":"l3","DOI":"10.1086\/504490","article-title":"Invasive fungal pathogens: current epidemiological trends","volume":"43","author":"Pfaller","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0029-1246289","article-title":"Invasive fungal infections in the intensive care unit","volume":"31","author":"Vazquez","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/eri.09.67","article-title":"New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance","volume":"7","author":"Fera","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.04.018_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jac\/39.5.655","article-title":"The use of commercially available lipid emulsions for the preparation of amphotericin B\u2013lipid admixtures","volume":"39","author":"Shadkhan","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/44.6.787","article-title":"Antifungal activity of amphotericin B\u2013lipid admixtures in experimental systemic candidosis in na\u00efve mice","volume":"44","author":"Shadkchan","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jac\/48.2.245","article-title":"Treatment of experimental candidosis with amphotericin B\u2013Intralipid admixtures in immunocompromised mice","volume":"48","author":"Shadkchan","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13693780310001598871","article-title":"Treatment of murine systemic aspergillosis with polyene-intralipid admixtures","volume":"42","author":"Sionov","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0045","series-title":"Fungal infection. Diagnosis and management","first-page":"41","year":"2003"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/1381612023395853","article-title":"Pharmaceutical design of the liposomal antimicrobial agents for infectious disease","volume":"8","author":"Moribe","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0055","first-page":"67","article-title":"Development of liposomal polyene antibiotics: an historical perspective","volume":"6","author":"Ng","year":"2003","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11046-009-9271-z","article-title":"Nystatin\u2013intralipid preparation: characterization and in vitro activity against yeasts and molds","volume":"169","author":"Semis","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0065","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/jb.172.7.3898-3904.1990","article-title":"Isolation of the Candida albicans histidinol dehydrogenase (HIS4) gene and characterization of a histidine auxotroph","volume":"172","author":"Altboum","year":"1990","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/00362178185380441","article-title":"Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals","volume":"19","author":"Segal","year":"1981","journal-title":"Sabouraudia"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0928-8244(03)00230-X","article-title":"Polyene and cytokine treatment of experimental aspergillosis","volume":"39","author":"Sionov","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2005.10.015","article-title":"Efficacy of amphotericin B or amphotericin B\u2013intralipid in combination with caspofungin against experimental aspergillosis","volume":"53","author":"Sionov","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2004.07.014","article-title":"Antifungal effect and possible mode of activity of a compound from the marine sponge Dysidea herbacea","volume":"50","author":"Sionov","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00437281","article-title":"Systemic candidiasis in mice immunized with Candida albicans ribosomes","volume":"91","author":"Levy","year":"1985","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1439-0507.1988.tb03867.x","article-title":"Kidney function in experimental systemic candidosis of mice","volume":"31","author":"Ryley","year":"1988","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0105","series-title":"Principles and practice of infectious diseases","article-title":"Candida species","author":"Edwards","year":"2005"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(05)67381-3","article-title":"Advances and challenges in management of invasive mycoses","volume":"366","author":"Patterson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.04.018_bib0115","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: when and how to treat","volume":"68","author":"R\u00fcping","year":"2008","journal-title":"Drugs"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T19:20:45Z","timestamp":1543605645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0924857911002196"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.04.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}